CHEK1 and ovarian cancer: 3.8. Olaparib Combined with Blockage of ATR/CHK1 Enhances DNA Double-Strand Breaks Irrespective of RAD51-Mediated HR Activity in BRCA2MUT Ovarian Cancer Cells